Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. ORPH.L Share Price
  4. ORPH.L Share Regulatory News
  5. Open Orphan

Pin to quick picksORPH.L Regulatory News (ORPH)

ORPH.L Information
  • There is currently no data for ORPH

Open Orphan

15 Jan 2020 17:30

RNS Number : 9383Z
FTSE Russell
15 January 2020
 

 

 

 

 

Open Orphan (UK): Merger with Hvivo (UK)Changes in FTSE UK Index Series

15 January 2020

Subject to the completion of the merger between Open Orphan (UK, constituent) and Hvivo (UK, constituent), please see details of affected indexes and effective dates below:

 

 

Index

Effective FromStart of Trading

FTSE AIM All-Share Index

20 January 2020

 

* The number of shares is based on the merger terms of 2.47 new Open Orphan shares for every Hvivo share held.

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 4563 6346

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2020 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FTSSFWFIIESSEIF
123456789
Date   Source Headline
17th Feb 202212:05 pmRNSPositive results from RSV Human Challenge Study
14th Feb 20227:00 amRNSLaunch of STRiVE project
2nd Feb 20227:00 amRNSWorld’s first COVID-19 Characterisation Study
26th Jan 20224:40 pmRNSSecond Price Monitoring Extn
26th Jan 20224:36 pmRNSPrice Monitoring Extension
20th Jan 20227:00 amRNSMalaria Human Challenge Model Launched
21st Dec 20217:00 amRNS£5m Influenza human challenge study contract win
16th Dec 20214:41 pmRNSSecond Price Monitoring Extn
16th Dec 20214:35 pmRNSPrice Monitoring Extension
10th Dec 202111:05 amRNSSecond Price Monitoring Extn
10th Dec 202111:00 amRNSPrice Monitoring Extension
10th Dec 20217:05 amRNSExercise of Options
10th Dec 20217:00 amRNS$13.4m Influenza HCS contract win
6th Dec 20217:00 amRNSPositive results from Flu Human Challenge Study
19th Nov 20217:00 amRNSImutex Vaccine Phase I Study Results
17th Nov 20217:00 amRNS£5.1m RSV contract
15th Nov 20217:00 amRNS£1.5m Contract renewal for Venn Life Sciences
13th Oct 20217:00 amRNSDirectorate Change
20th Sep 20217:00 amRNSHalf-year Report
20th Sep 20217:00 amRNS£5.7m Influenza human challenge study contract win
9th Sep 20217:00 amRNSNotice of Results
7th Sep 20217:00 amRNSPositive results from RSV Human Challenge Study
24th Aug 20219:05 amRNSSecond Price Monitoring Extn
24th Aug 20219:00 amRNSPrice Monitoring Extension
24th Aug 20217:00 amRNS£8.1m Asthma Human Challenge Study Contract Win
9th Aug 20217:00 amRNSMalaria Human Challenge Model
29th Jul 20217:00 amRNSDNDi Phase II trial support
22nd Jul 20217:00 amRNSNEJM Opinion Piece
21st Jul 202112:58 pmRNSResult of AGM
14th Jul 20219:06 amRNSDirectors’ Dealings
14th Jul 20218:04 amRNSAIM Schedule 1 update by Poolbeg Pharma plc
14th Jul 20217:01 amRNSNew Contract win for Open Orphan’s Breda office
14th Jul 20217:00 amRNSCOVID-19 Human Challenge Programme update
9th Jul 20217:00 amRNSHRV and Flu contract
7th Jul 20214:41 pmRNSSecond Price Monitoring Extn
7th Jul 20214:36 pmRNSPrice Monitoring Extension
30th Jun 20217:00 amRNS2020 Annual Report and 2021 AGM Notice
17th Jun 20217:00 amRNSFinal Results to 31 December 2020
17th Jun 20217:00 amRNSDemerger Update
14th Jun 20217:00 amRNSRe. Distribution in Specie and Notice of Results
11th Jun 20217:00 amRNSExercise of Warrants
19th May 20217:00 amRNSCourt Approval
10th May 20217:15 amRNSExercise of Share Options
10th May 20217:00 amRNS£3m COVID challenge virus manufacturing contract
29th Apr 202111:39 amRNSResult of General Meeting
13th Apr 20217:00 amRNSPotential demerger of certain non-core assets
9th Apr 20217:00 amRNSLaunch of Disease in Motion platform
31st Mar 20217:00 amRNSHolding(s) in Company
26th Mar 20217:00 amRNS£7.5m Human Challenge Study Contract
25th Mar 20217:00 amRNSCOVID-19 Human Challenge Programme update
123456789

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
SGWS
Is } Sri D
LSE
-1.44%
TFIF
Twentyfour Inc
LSE
0.00%
SDY
Speedy Hire
LSE
-0.84%
37QB
Jsc Halyk 144a
LSE
0.00%
SBEG
UBS BBG USD EM Sovereign UCITS ETF hGBP dis
LSE
-0.41%
Trending
BA.
BAE Systems
LSE
0.76%
SBTX
Skinbiotherap.
LSE
0.00%
PLE
Plethora Solutions Holdings Plc
LSE
0.00%
PREM
Premier African Minerals
LSE
9.52%
EZJ
easyJet
LSE
0.34%